Jubilant Life Sciences’ board of directors has formed a committee to evaluate strategic options for restructuring its business to create “focused entities” for its Pharmaceuticals and Life Science Ingredients business segments.
The committee is pondering whether to “create separate and focused entities for Pharmaceuticals and Life Science Ingredients businesses to manage...








